摘要
体外膜肺氧合(extrcorporeal memberane orygenation,ECMO)作为一种体外心肺功能的机械辅助技术,ECMO在严重呼吸系统疾病、婴幼儿危重症疾病、心肺复苏以及器官移植方面显示出可喜的优势。但作为一种新兴技术,ECMO在我国面临许多个性化问题,如费用昂贵、资源分配不均以及转运技术不成熟等。ECMO在临床上存在很多并发症,诸如出血与血栓、感染、急性肾损伤以及机械并发症,并发症的出现严重影响着患者的预后,应引起我们重视。
As a mechanically assisted technique for cardiopulmonary function in vitro,extracorporeal membrane oxygenation(ECMO)shows gratifying advantages in severe respiratory diseases,infant and child critical diseases,cardiopulmonary resuscitation,and organ transplantation.However,as an emerging technology,ECMO faces many personalized problems in China,such as high cost,uneven distribution of resources,and immature transfer technology.There are many clinical complications in ECMO patients,such as hemorrhage and thrombus,infection,acute kidney injury and mechanical complications.The occurrence of complications seriously affects the prognosis of patients,which calls for our attention.
作者
武兵(综述)
张敏
李倩(审校)
Wu Bing;Zhang Min;Li Qian(Emergency Department of Internal Medicine,Yijishan Hospital of Wannan Medical College,Wuhu 241001 China)
出处
《锦州医科大学学报》
2021年第5期99-104,共6页
Journal of Jinzhou Medical University
基金
2018年度安徽芜湖市科技计划项目,项目编号:2018cg29
2020年安徽省高等学校省级质量工程项目教学研究项目,项目编号:2020jyxm2118
2020年度皖南医学院教学质量与教学改革工程项目,2020kcbz11。
关键词
ECMO
临床应用
适应证
禁忌证
并发症
ECMO
clinical application
indication
contraindication
complication
